跳到主要內容

Krishnan Krish S 的 Form 4 申報

Krystal Biotech, Inc.(KRYS),2025/7/16 申報

申報編號
0001298709-25-000009
申報時間
2025/7/16
交易日
2025/7/14-7/16
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $539.5 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Krishnan Krish SCIK 0001298709董事、高階主管(總裁、執行長)、持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2025/7/14Common StockS賣出處分−13,400$150.30F2−$2,014,0201,512,529直接
2025/7/15Common StockS賣出處分−2,184$150.68F3−$329,085.121,510,345直接
2025/7/15Common StockS賣出處分−900$151.79F4−$136,6111,509,445直接
2025/7/16Common StockS賣出處分−1,389$150.00F4−$208,3501,508,056直接
2025/7/14Common StockS賣出處分−13,335$150.29F7−$2,004,117.151,443,376間接
2025/7/14Common StockS賣出處分−100$151.00F4−$15,1001,443,276間接
2025/7/15Common StockS賣出處分−2,236$150.68F9−$336,920.481,441,040間接
2025/7/15Common StockS賣出處分−800$151.79F4−$121,4321,440,240間接
2025/7/16Common StockS賣出處分−1,529$150.00F4−$229,3501,438,711間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The transaction was executed in multiple trades ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

F3

The transaction was executed in multiple trades ranging from $150.21 to $151.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

F4

The transaction was executed in one trade.

表 I 有 5 筆交易的價格引用這則附註。

F7

The transaction was executed in multiple trades ranging from $150.00 to $150.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

F9

The transaction was executed in multiple trades ranging from $150.21 to $151.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)